Results 121 to 130 of about 80,865 (200)

FDA approval of prademagene zamikeracel (Zevaskyn): advancing gene therapy for recessive dystrophic epidermolysis bullosa (RDEB) patients. [PDF]

Ann Med Surg (Lond)
Shahid SR, Shahid K, Khalid M, Waafira A.   +3 more
europepmc   +1 more source

Analysis of cortical dysplasias using b-tensor encoding diffusion MRI in an animal model. [PDF]

PLoS One
Ortega-Fimbres O, Ríos-Carrillo R, Gaspar-Martínez E, Ruiz-Acosta P, Regalado M, Luna-Munguía H, Ramírez-Manzanares A, Concha L.   +7 more
europepmc   +1 more source

Reaction-induced departures from continuum Navier-Stokes turbulence. [PDF]

Proc Natl Acad Sci U S A
Williams CT, McMullen RM, Gallis MA.
europepmc   +1 more source

Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension. [PDF]

J Prev Alzheimers Dis
Zimmer JA, Sims JR, Evans CD, Nery ESM, Wang H, Wessels AM, Tronchin G, Sato S, Raket LL, Andersen SW, Sapin C, Paget MA, Gueorguieva I, Ardayfio P, Khanna R, Brooks DA, Matthews BR, Mintun MA, Alzheimer’s Disease Neuroimaging Initiative.   +18 more
europepmc   +1 more source

ConMonity: An IoT-Enabled LoRa/LTE-M Platform for Multimodal, Real-Time Monitoring of Concrete Curing in Construction Environments. [PDF]

Sensors (Basel)
Namatēvs I, Gaigals G, Ozols K.
europepmc   +1 more source

AI-Native PHY-Layer in 6G Orchestrated Spectrum-Aware Networks. [PDF]

Sensors (Basel)
Mutescu PM, Petrariu AI, Coca E, Patachia-Sultanoiu C, Mihai RM, Lavric A.   +5 more
europepmc   +1 more source

Enhanced spectrum sensing for 5G and LTE signals using advanced deep learning models and hyperparameter tuning. [PDF]

Sci Rep
Elmorsy SMA, Osman SM, Gamel SA.
europepmc   +1 more source

What If Each Voxel Were Measured With a Different Diffusion Protocol? [PDF]

Magn Reson Med
Coelho S, Lemberskiy G, Zhu A, Lee HH, Abad N, Foo TKF, Fieremans E, Novikov DS.   +7 more
europepmc   +1 more source

Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials. [PDF]

BMJ Open
Strand V, Schulze-Koops H, Al-Emadi S, Kinch CD, Gruben D, Germino R, Connell CA, Mysler E.   +7 more
europepmc   +1 more source

Integrating CRISPR technology into neurotrauma research: opportunities and challenges in addressing synaptic dysfunction after TBI. [PDF]

Ann Med Surg (Lond)
Ullah H, Ahmad R, Khalid M, Talha M, Waafira A.   +4 more
europepmc   +1 more source